| Literature DB >> 33178577 |
Jie Fan1,2, Qigen Fang1, Yang Yang3, Meng Cui1, Ming Zhao1, Jinxing Qi1, Ruihua Luo1, Wei Du1,4, Shanting Liu1, Qiang Sun2.
Abstract
OBJECTIVE: To analyze the role of frequency of heterotypic neutrophil-in-tumor structure (FNiT) in the prognosis of patients with buccal mucosa squamous cell carcinoma (BMSCC).Entities:
Keywords: buccal mucosa squamous cell carcinoma; cell-in-cell; disease-specific survival; frequency of heterotypic neutrophil-in-tumor structure; prognosis; recurrence-free survival
Year: 2020 PMID: 33178577 PMCID: PMC7593655 DOI: 10.3389/fonc.2020.541878
Source DB: PubMed Journal: Front Oncol ISSN: 2234-943X Impact factor: 6.244
Figure 1Fluorescent staining result of typical heterotypic NiT structure formed between H157 cells and neutrophils. H157-H1 and H157-H2 are well-differentiated BMSCC cell lines with high FNiT, and H157-L1 and H157-L2 are poorly differentiated BMSCC cell lines with low FNiT. Cells marked in red and green are H157 cells and neutrophils, respectively. The regions marked in blue are the nuclei of H157 cells and neutrophils. Scale bar of all: 100 mm.
General clinicopathological information of enrolled patients.
| Variables | Number(%) |
|---|---|
| Age(years) | |
| <60 | 67(46%) |
| ≥60 | 78(54%) |
| Sex | |
| Male | 77(53%) |
| Female | 68(47%) |
| FNiT | |
| Low | 67(46%) |
| High | 78(54%) |
| Smoker | |
| Y | 81(56%) |
| N | 64(44%) |
| Drinker | |
| Y | 45(31%) |
| N | 100(69%) |
| Betel nut chewing | |
| Positive | 15(10%) |
| Negative | 130(90%) |
| Tumor stage | |
| T1+T2 | 65(45%) |
| T3+T4 | 80(55%) |
| Node stage | |
| N0 | 100(69%) |
| N+ | 45(31%) |
| Metastasis | |
| Positive | 11(8%) |
| Negative | 134(92%) |
| Disease stage | |
| I+II | 59(41%) |
| III+IV | 86(59%) |
| Lymphovascular invasion | |
| Positive | 10(7%) |
| Negative | 135(93%) |
| Locoregional recurrence | |
| Y | 80(55%) |
| N | 65(45%) |
| Extranodal extension | |
| Y | 21(14.5%) |
| N | 124(85.5%) |
| Perineural invasion | |
| Y | 8(5.5%) |
| N | 137(94.5%) |
| Tumor Grade | |
| Low | 10(7%) |
| Median | 26(18%) |
| High | 109(75%) |
Figure 2Typical NiT structures formation in BMSCC tissue. (A) Representative image for E-cadherin staining in BMSCC pathologic tissue with extensive neutrophils infiltration. Typical NiT structures are indicated with red asterisks. Scale bar: 50 mm. (B–D) Zoomed in images for boxed NiT structures in (A). Each of them is one typical NiT structure. Inserted pictures of each image are schematic cartoons for the indicated NiT structures. FNiT=t/T. (t: the total number of NiT structures. T: the total number of the tumor cells.)
Figure 3Images of BMSCC tissue with different levels of FNiT and FNiT distribution in enrolled patients. (A, B) Representative images of pathologic tissues with high FNiT in two patients with BMSCC. Scale bar: 50 mm. (C, D) Representative images of pathologic tissues with low FNiT in two patients with BMSCC. Scale bar: 50 mm. (E) Histogram plot for FNiT distribution in enrolled patients. The cutoff value of the FNiT was calculated by the mean value of the FNiT in enrolled patients.
Association between FNiT and clinicopathological characteristics.
| Variables | FNiT | P-value | |
|---|---|---|---|
| Low (<4.2‰) n = 67 | High (≥4.2‰) n = 78 | ||
| Age(years) | 0.749 | ||
| <60 | 30 | 37 | |
| ≥60 | 37 | 41 | |
| Sex | 0.298 | ||
| Male | 32 | 44 | |
| Female | 35 | 34 | |
| Smoker | 0.886 | ||
| Y | 37 | 44 | |
| N | 30 | 34 | |
| Drinker | 0.519 | ||
| Y | 19 | 26 | |
| N | 48 | 52 | |
| Betel nut chewing | 0.291 | ||
| Positive | 5 | 10 | |
| Negative | 62 | 68 | |
| Tumor stage | 0.510 | ||
| T1+T2 | 32 | 33 | |
| T3+T4 | 35 | 45 | |
| Node stage | 0.941 | ||
| N0 | 46 | 54 | |
| N+ | 21 | 24 | |
| Metastasis | 0.190 | ||
| Positive | 3 | 8 | |
| Negative | 64 | 70 | |
| Disease stage | 0.353 | ||
| I+II | 30 | 29 | |
| III+IV | 37 | 49 | |
| Lymphovascular invasion | 0.085 | ||
| Positive | 2 | 8 | |
| Negative | 65 | 70 | |
| Extranodal extension | 0.697 | ||
| Y | 9 | 12 | |
| N | 58 | 66 | |
| Perineural invasion | 0.296 | ||
| Y | 3 | 5 | |
| N | 65 | 72 | |
| Tumor Grade | <0.001 | ||
| Low | 8 | 2 | |
| Median | 19 | 7 | |
| High | 40 | 69 | |
Univariate and multivariate analyses of predictors for recurrence-free survival in patients with BMSCC.
| Variables | Univariate | Cox model | |
|---|---|---|---|
| P-value | P-value | OR(95% CI) | |
| Age,years(<60 vs ≥60) | 0.591 | ||
| Sex(male vs female) | 0.220 | ||
| Smoker (Y vs N) | 0.681 | ||
| Drinker (Y vs N) | 0.580 | ||
| Betel nut chewing(Y vs N) | <0.001 | 0.180 | 2.046(0.718–5.831) |
| FNiT(Low vs High) | 0.001 | 0.018 | 1.803(1.106–2.940) |
| Tumor stage(T1+T2 vs T3+T4) | 0.016 | 0.953 | 1.036(0.327–3.276) |
| Node stage(N0 vs N+) | 0.342 | ||
| Metastasis(Y vs N) | <0.001 | 0.744 | 1.252 (0.325–4.821) |
| Disease stage(I+II vs III+IV) | 0.001 | 0.313 | 1.907(0.545–6.671) |
| Lymphovascular invasion(Y vs N) | 0.634 | ||
| Extranodal extension(Y vs N) | 0.268 | ||
| Perineural invasion(Y vs N) | 0.521 | ||
| Tumor Grade | 0.042 | 0.176 | 1.365(0.870–2.143) |
| Low | |||
| Median | |||
| High | |||
Figure 4Recurrence-free survival function in patients with different FNiT (p = 0.018).
Univariate and multivariate analyses of predictors for disease-specific survival in patients with BMSCC.
| Variables | Univariate | Cox model | |
|---|---|---|---|
| P-value | P-value | OR(95% CI) | |
| Age,years(<60 vs ≥60) | 0.456 | ||
| Sex(male vs female) | 0.558 | ||
| Smoker (Y vs N) | 0.993 | ||
| Drinker (Y vs N) | 0.701 | ||
| Betel nut chewing(Y vs N) | 0.001 | 0.236 | 1.888(0.660–5.398) |
| FNiT(Low vs High) | <0.001 | 0.034 | 1.677(1.039–2.706) |
| Tumor stage(T1+T2 vs T3+T4) | 0.001 | 0.941 | 0.954(0.275–3.305) |
| Node stage(N0 vs N+) | 0.533 | ||
| Metastasis(Y vs N) | 0.002 | 0.907 | 0.920 (0.228–3.709) |
| Disease stage(I+II vs III+IV) | <0.001 | 0.174 | 2.524(0.664–9.586) |
| Lymphovascular invasion(Y vs N) | 0.038 | 0.068 | 2.122(0.946–4.757) |
| Extranodal extension(Y vs N) | 0.467 | ||
| Perineural invasion(Y vs N) | 0.573 | ||
| Tumor Grade | <0.001 | 0.003 | 2.371(1.337–4.203) |
| Low | |||
| Median | |||
| High | |||
Figure 5Disease-specific survival function in patients with different FNiT (p = 0.034).
Figure 6Disease-specific survival function in patients with different levels of tumor grade (p = 0.003).